Overview

16.0040 Ankylosing Spondylitis Study

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate extended safety and efficacy of etanercept in adults with Ankylosing Spondylitis.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Collaborator:
Immunex Corporation
Treatments:
Etanercept